An evaluation of gait and patient experience of two newly developed stance-control knee joints for custom-made KAFO*s, a pilot study.

An evaluation of gait and patient experience of two newly developed stance-control knee joints for custom-made KAFO*s, a pilot study. - Evaluation of two new joints for SC-KAFO's.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30641

Enrollment

Registered

2007-02-13

Start date

2007-02-15

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

quadriceps muscle paresis quadriceps muscle weakness

Interventions

Walking with two new types of stance-control, knee-ankle-footortheses. Each new sc-kevo will be worn for a period of 4 weeks, at the end of this 4-week period the evaluation will take place by using

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) quadriceps muscle weakness, 2) Currently successful users of a KAFO with locked joint or a SC-KAFO, 3) ability to walk 6 minutes, 4) age 18-70

Exclusion criteria

Exclusion criteria: Co-morbid disease that limits physical exercise tolerande or limits the patient in visiting the hospital to participate in the study protocol.

Design outcomes

Primary

Measure	Time frame
The effective use in daily life of the two new sc-kafo's in patients with quadriceps weakness.	—

Secondary

Measure	Time frame
1) Energy expenditure during walking: Oxygen cost per meter 2) Spatio-temporal parameters of gait (velocity, cadence, step length) 3) Kinematic en kinetic parameters of gait (jiont angles en moments of the ankle, knee, hip and trunk) 4) Comfort and experienced functioning with the new sc-kevo's.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)